Primary care physicians’ perspective on financial issues and adult immunization in the Era of the Affordable Care Act

Vaccine

Volumn 35, Issue 4, 2017, Pages 647-654

  Hurley, Laura P ^a,b   Lindley, Megan C ^c   Allison, Mandy A ^a   Crane, Lori A ^a   Brtnikova, Michaela ^a   Beaty, Brenda L ^a   Snow, Megan ^a   Bridges, Carolyn B ^c   Kempe, Allison ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Adults; Preventive care; Vaccine financing; Vaccine reimbursement; Vaccines

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ADULT; ARTICLE; AWARENESS; CHICKENPOX; COMPARATIVE STUDY; CONTROLLED STUDY; DIPHTHERIA; DRUG COST; E-MAIL; FEMALE; FINANCIAL MANAGEMENT; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNIZATION; INFLUENZA VACCINATION; INTERNIST; MALE; MANAGED CARE; MEASLES; MEDICAID; MEDICARE; MENINGOCOCCOSIS; MIDDLE AGED; MUMPS; PAPILLOMAVIRUS INFECTION; PERTUSSIS; PHYSICIAN ATTITUDE; PNEUMOCOCCAL INFECTION; PREFERRED PROVIDER ORGANIZATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRIVATE SECTOR; PUBLIC HEALTH INSURANCE; PURCHASING; REIMBURSEMENT; RUBELLA; SATISFACTION; SEASONAL INFLUENZA; TETANUS; VACCINATION REFUSAL; ECONOMICS; PSYCHOLOGY; QUESTIONNAIRE; UTILIZATION;

ADULT; FEMALE; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHYSICIANS, PRIMARY CARE; SURVEYS AND QUESTIONNAIRES; VACCINES;

EID: 85009285438     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.12.007     Document Type: Article

References (48)

1. [1] Williams WW, Lu PJ, O'Halloran A, et al. Surveillance of vaccination coverage among adult populations - United States, 2014. Morbidity and mortality weekly report. Surveillance summaries (Washington, DC, 2002), VOL. 65(1);2016. p. 1–36.
2. [2] Shen, A.K., Sobzcyk, E., Buchanan, A., Wu, L., Duggan-Goldstein, S., Second National Immunization Congress 2010: addressing vaccine financing for the future in the US. Hum Vaccin 7:1 (2011), 12–18.
3. [3] Hurley, L.P., Lindley, M.C., Harpaz, R., et al. Barriers to the use of herpes zoster vaccine. Ann Int Med 152:9 (2010), 555–560.
4. [4] Hurley, L.P., Bridges, C.B., Harpaz, R., et al. U.S. Physicians' perspective of adult vaccine delivery. Ann Int Med, 160(3), 2014, 161.
5. [5] Centers for Disease Control and Prevention, National, State, and selected local area vaccination coverage among children aged 19–35 months - United States 2014. MMWR – Morb Mortal Wkly Rep 64:33 (2014), 889–896.
6. [6] Centers for Disease Control and Prevention, Benefits from immunization during the vaccines for children program Era - United States, 1994–2013. MMWR – Morb Mortal Wkly Rep, 63(16), 2014 352-255.
7. [7] Freed, G.L., Clark, S.J., Konrad, T.R., Pathman, D.E., Variation in patient charges for vaccines and well-child care 8. Arch Pediatr Adolesc Med 150:4 (1996), 421–426.
8. [8] Freed, G.L., Cowan, A.E., Clark, S.J., Primary care physician perspectives on reimbursement for childhood immunizations. Pediatric 122:6 (2008), 1319–1324.
9. [9] Freed, G.L., Cowan, A.E., Gregory, S., Clark, S.J., Variation in provider vaccine purchase prices and payer reimbursement. Pediatrics 122:6 (2008), 1325–1331.
10. [10] Lindley, M.C., Shen, A.K., Orenstein, W.A., Rodewald, L.E., Birkhead, G.S., Financing the delivery of vaccines to children and adolescents: challenges to the current system. Pediatrics 124:Suppl. 5 (2009), S548–S557.
11. [11] O'Leary, S.T., Allison, M.A., Lindley, M.C., et al. Vaccine financing from the perspective of primary care physicians. Pediatrics 133:3 (2014), 367–374.
12. [12] Stewart, A.M., Lindley, M.C., Chang, K.H., Cox, M.A., Vaccination benefits and cost-sharing policy for non-institutionalized adult Medicaid enrollees in the United States. Vaccine 32:5 (2014), 618–623.
13. [13] Centers for Medicare and Medicaid Services. Medicare Enrollment Data by State and Age as of July 1, 2012; 2012; < https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/MedicareEnrpts/Downloads/Sageall12.pdf> [accessed February 24, 2016].
14. [14] Centers for Medicare and Medicaid Services. On its 50th anniversary, more than 55 million Americans covered by Medicare; 2015; < https://www.cms.gov/Newsroom/MediaReleaseDatabase/Press-releases/2015-Press-releases-items/2015-07-28.html> [accessed February 24, 2016].
15. [15] University of Colorado. Vaccine Policy Collaborative Initiative; 2016; < http://www.ucdenver.edu/academics/colleges/medicalschool/programs/outcomes/childrensoutcomesreserach/VaccinePolicyCollaborativeInitiative/Pages/default.aspx> [accessed August 10, 2015].
16. [16] Crane, L.A., Daley, M.F., Barrow, J., et al. Sentinel physician networks as a technique for rapid immunization policy surveys. Eval Health Prof 31:1 (2008), 43–64.
17. [17] Vovici Feedback [computer program]. Melville, NY: Verint Systems Inc; 2015.
18. [18] Dillman, D.A., Smyth, J., Christian, L.M., Internet, mail and mixed-mode surveys: the tailored desgin method, 3rd ed., 2009, John Wiley Co, New York, NY.
19. [19] Atkeson, L.R., Adams, A.N., Bryant, L.A., Zilberman, L., Saunder, K.L., Considering mixed mode surveys for questions in political behavior: using the internet and mail to get quality data at reasonable costs. Political Behavior 33:1 (2011), 161–178.
20. [20] McMahon, S.R., Iwamoto, M., Massoudi, M.S., et al. Comparison of e-mail, fax, and postal surveys of pediatricians. Pediatrics 111:4 Pt 1 (2003), e299–e303.
21. [21] Nichol, K.L., Lofgren, R.P., Gapinski, J., Influenza vaccination. Knowledge, attitudes, and behavior among high-risk outpatients. Arch Int Med 152:1 (1992), 106–110.
22. [22] Nichol, K.L., Mac Donald, R., Hauge, M., Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J General Int Med 11:11 (1996), 673–677.
23. [23] Armstrong, K., Berlin, M., Schwartz, J.S., Propert, K., Ubel, P.A., Barriers to influenza immunization in a low-income urban population. Am J Prev Med 20:1 (2001), 21–25.
24. [24] Winston, C.A., Wortley, P.M., Lees, K.A., Factors associated with vaccination of Medicare beneficiaries in five U.S. communities: results from the racial and ethnic adult disparities in immunization initiative survey, 2003. J Am Geriatrics Soc 54:2 (2006), 303–310.
25. [25] Ding, H., Black, C.L., Ball, S., et al. Influenza vaccination coverage among pregnant women-United States, 2014–15 influenza season. MMWR Morb Mortal Wkly Rep 64:36 (2015), 1000–1005.
26. [26] U.S. Government Accountability Office. Medicare: many factors, including administrative challenges, affect access to Part D vaccinations; 2011 < http://www.gao.gov/products/GAO-12-61> [accessed February 24, 2016].
27. [27] National Vaccine Advisory Committee, Recommendations from the National Vaccine Advisory committee: standards for adult immunization practice. Public Health Rep 129:2 (2014), 115–123.
28. [28] Centers for Disease C, Prevention. Recommended adult immunization schedule–United States, 2002–2003. MMWR Morb Mortal Wkly Rep 51:40 (2002), 904–908.
29. [29] Centers for Disease Control and Prevention, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 61:40 (2012), 816–819.
30. [30] Tomczyk, S., Bennett, N.M., Stoecker, C., et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >/=65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 63:37 (2014), 822–825.
31. [31] Centers for Disease Control and Prevention, Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women–Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 62:7 (2013), 131–135.
32. [32] MacNeil, J.R., Rubin, L., Folaranmi, T., Ortega-Sanchez, I.R., Patel, M., Martin, S.W., Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep 64:41 (2015), 1171–1176.
33. [33] Cohn, A.C., MacNeil, J.R., Clark, T.A., et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62:RR-2 (2013), 1–28.
34. [34] Kretsinger, K., Broder, K.R., Cortese, M.M., et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 55:RR-17 (2006), 1–37.
35. [35] Markowitz, L.E., Dunne, E.F., Saraiya, M., et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 63:RR-05 (2014), 1–30.
36. [36] Harpaz, R., Ortega-Sanchez, I.R., Seward, J.F., Advisory committee on immunization practices centers for disease control and prevention. prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 57:RR-5 (2008), 1–30 quiz CE32-34.
37. [37] Centers for Disease C, Prevention. CDC Adult Vaccine Price L;. 2015.
38. [38] Prevention CfDCa. Vaccine-Preventable Adult Diseases; 2016 [accessed 11/29/2016].
39. [39] RAND Corporation. Health Coverage Grows Under Affordable Care Act; 2016 < http://www.rand.org/news/press/2015/05/06.html> [accessed March 2, 2016].
40. [40] Lal, H., Cunningham, A.L., Heineman, T.C., Adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med 373:16 (2015), 1576–1577.
41. [41] Stewart, A.M., Lindley, M.C., Cox, M.A., Medicaid provider reimbursement policy for adult immunizations. Vaccine 33:43 (2015), 5801–5808.
42. [42] Centers for medicare and medicaid services. License for Use of Current Procedural Terminology, Fourth Edition (“CPT®”). < https://www.cms.gov/apps/physician-fee-schedule/license-agreement.aspx> [accessed March 30, 2016].
43. [43] Immunization Work Group of the N, Global Public Health Committee of the Infectious Diseases Society of A, Actions to strengthen adult and adolescent immunization coverage in the United States: policy principles of the Infectious Diseases Society of America. Clin Infect Dis 44:12 (2007), e104–e108.
44. [44] Immunization Work Group of the N, Global Public Health Committee of the Infectious Diseases Society of A, Executive summary – actions to strengthen adult and adolescent immunization coverage in the United States: policy principles of the Infectious Diseases Society of America. Clin Infect Dis 44:12 (2007), 1529–1531.
45. [45] TransactRx. Medical Billing Company; 2014 < http://www.transactrx.com/>.
46. [46] Orenstein, W.A., Mootrey, G.T., Pazol, K., Hinman, A.R., Financing immunization of adults in the United States. Clin Pharmacol Ther 82:6 (2007), 764–768.
47. [47] Medicare Payment Advisory Commission. Issues in Medicare coverage of drugs; Report to the Congress: Promoting Greater Efficiency in Medicare; 2007. p. 157–86. Available at: < www.medpac.gov/chapters/Jun07_Ch07.pdf> [accessed December 27, 2012].
48. [48] Hickner, J., Thompson, P.J., Wilkinson, T., et al. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results. J Am Board Fam Med 27:2 (2014), 268–274.